FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Pravastatin Sodium Recall

Pravastatin Sodium USP, tablets, 40 mg, 90-count bottle, Rx only, Manufactured for: Lup…

Lupin Limited · Vasco Da Gama, N/A

Risk level
Class II
Reported by FDA
Nov 29, 2017
Recall ID
D-0092-2018
Check your lot numberHow we source this data

Summary

Lupin recalled Pravastatin Sodium starting Nov 17, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0092-2018 on Nov 29, 2017. Reason: Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle. Status: Terminated.

Why it was recalled

Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.

Product description

Pravastatin Sodium USP, tablets, 40 mg, 90-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-487-09

Lot numbers, UPCs & expiration codes

Lot # G702459, Exp 2/20

Where it was sold

Product was distributed throughout the United States, including Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0092-2018
Classification
Class II
Status
Terminated
Recall initiated
Nov 17, 2017
FDA report date
Nov 29, 2017
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Limited

Original FDA data

Every field from FDA enforcement report D-0092-2018, exactly as published.

Show all FDA fields
City
Vasco Da Gama
Status
Terminated
Country
India
Event ID
78566
Address
15 - B I Phase 1a
Address (line 2)
I D C Verna Industrial Road
Code information
Lot # G702459, Exp 2/20
Report date
Nov 29, 2017
Product type
Drugs
Recall number
D-0092-2018
Classification
Class II
Recalling firm
Lupin Limited
Termination date
Mar 15, 2019
Reason for recall
Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pravastatin Sodium USP, tablets, 40 mg, 90-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-487-09
Distribution pattern
Product was distributed throughout the United States, including Puerto Rico.
Recall initiation date
Nov 17, 2017
Initial firm notification
Letter
Center classification date
Nov 21, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0092-2018, published Nov 29, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls